Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01109316
What this trial is testing

Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 132
Early research (Phase 1)Ended earlyNCT04141423
What this trial is testing

Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil

Who this might be right for
Type 1 Diabetes Mellitus (T1DM)
Biocon Limited 55
Not applicableStudy completedNCT04892069
What this trial is testing

Investigating the Effect of Ryzodeg® in Adult Patients With Type 2 Diabetes in Lebanon

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 60
Not applicableStudy completedNCT00670722
What this trial is testing

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 6,500
Large-scale testing (Phase 3)Study completedNCT02648217
What this trial is testing

Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 263
Early research (Phase 1)Study completedNCT01707160
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 24
Early research (Phase 1)Study completedNCT01620450
What this trial is testing

Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy Japanese

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 34
Not applicableStudy completedNCT00755833
What this trial is testing

Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 270
Testing effectiveness (Phase 2)Study completedNCT01194258
What this trial is testing

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type II
Halozyme Therapeutics 132
Large-scale testing (Phase 3)Study completedNCT03874715
What this trial is testing

Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine

Who this might be right for
Type 1 Diabetes Mellitus
Sanofi 210
Post-approval studies (Phase 4)Study completedNCT00771693
What this trial is testing

Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)

Who this might be right for
Type 2 Diabetes MellitusPostprandial Hyperglycemia
Karolinska Institutet 18
Post-approval studies (Phase 4)Study completedNCT00624364
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 140
Not applicableStudy completedNCT03416855
What this trial is testing

A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in Korea

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 768
Large-scale testing (Phase 3)Study completedNCT00434954
What this trial is testing

Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 494
Large-scale testing (Phase 3)Study completedNCT00046150
What this trial is testing

12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.

Who this might be right for
Diabetes, Type I
Sanofi 59
Not applicableStudy completedNCT01542060
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 298
Not applicableStudy completedNCT01542424
What this trial is testing

An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,889
Large-scale testing (Phase 3)Study completedNCT00832182
What this trial is testing

Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 75
Post-approval studies (Phase 4)Study completedNCT01966978
What this trial is testing

The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study

Who this might be right for
Diabetes Mellitus, Type 2Diabetes
University of Texas Southwestern Medical Center 157
Post-approval studies (Phase 4)Study completedNCT01889095
What this trial is testing

Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients

Who this might be right for
Diabetes Type 2
Tehran University of Medical Sciences 160
Next Page